JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
Boston Omaha
BOC
$428M
| $343K | ﹤0.01% |
18,231
+760
| +4% | +$15.4K |
|
4527
iShares North American Natural Resources ETF
IGE
$741M
| $343K | ﹤0.01% |
8,834
-4,568
| -34% | -$177K |
|
|
AEVA
4528
Aeva Technologies
AEVA
$1.2B
| $342K | ﹤0.01% |
54,781
-8,420
| -13% | -$48K |
|
4529
Riley Exploration Permian
REPX
$744M
| $342K | ﹤0.01% |
9,580
+1,146
| +14% | +$44.7K |
|
4530
CALL
Baxter International
BAX
$13.5B
| $342K | ﹤0.01% |
7,500
| – | – |
|
4531
WisdomTree US MidCap Fund
EZM
$940M
| $341K | ﹤0.01% |
6,448
+138
| +2% | +$6.85K |
|
|
BHR
4532
Braemar Hotels & Resorts
BHR
$156M
| $341K | ﹤0.01% |
84,826
+13,133
| +18% | +$51.8K |
|
4533
Gevo
GEVO
$360M
| $340K | ﹤0.01% |
223,560
-88,195
| -28% | -$114K |
|
4534
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$563M
| $340K | ﹤0.01% |
4,965
-1,598
| -24% | -$108K |
|
4535
Triple Flag Precious Metals
TFPM
$5.94B
| $339K | ﹤0.01% |
+24,629
| New | +$371K |
|
4536
Xponential Fitness
XPOF
$273M
| $337K | ﹤0.01% |
19,541
+3,321
| +20% | +$94K |
|
4537
Arrow Financial
AROW
$659M
| $336K | ﹤0.01% |
17,181
-2,102
| -11% | -$43K |
|
4538
MetroCity Bankshares
MCBS
$1.01B
| $335K | ﹤0.01% |
18,749
+4,278
| +30% | +$71.8K |
|
4539
PUT
Prothena Corp
PRTA
$425M
| $335K | ﹤0.01% |
+4,900
| New | +$316K |
|
|
PETQ
4540
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $334K | ﹤0.01% |
22,026
+87
| +0.4% | +$1.12K |
|
4541
ProShares UltraPro Dow 30
UDOW
$841M
| $334K | ﹤0.01% |
11,192
-264
| -2% | -$7.49K |
|
4542
iShares Global Consumer Discretionary ETF
RXI
$260M
| $333K | ﹤0.01% |
2,125
-195
| -8% | -$28.6K |
|
4543
TETRA Technologies
TTI
$1.14B
| $333K | ﹤0.01% |
98,496
-605
| -0.6% | -$1.75K |
|
4544
Avita Medical
RCEL
$135M
| $332K | ﹤0.01% |
19,492
+12,846
| +193% | +$188K |
|
4545
MBIA
MBI
$261M
| $331K | ﹤0.01% |
38,290
-130
| -0.3% | -$1.17K |
|
4546
Ocular Therapeutix
OCUL
$1.79B
| $331K | ﹤0.01% |
64,111
+170
| +0.3% | +$1.01K |
|
|
TWIO
4547
DELISTED
Trajan Wealth Income Opportunities ETF
TWIO
| $331K | ﹤0.01% |
38,246
+22,840
| +148% | +$197K |
|
4548
Nature's Sunshine
NATR
$354M
| $330K | ﹤0.01% |
24,211
+3,109
| +15% | +$35.4K |
|
|
FFIC
4549
DELISTED
Flushing Financial
FFIC
| $330K | ﹤0.01% |
26,888
-27,021
| -50% | -$340K |
|
4550
PUT
JetBlue
JBLU
$2.28B
| $330K | ﹤0.01% |
+37,200
| New | +$270K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.